TAIPEI, Oct. 1, 2025 /PRNewswire/ -- TAHO Pharmaceuticals Ltd. ("TAHO Pharma") today announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TAH3311, the world's first Apixaban Oral Dissolving Film (ODF). This submission marks a...
Hence then, the article about taho pharma announces submission of new drug application nda to the u s fda for tah3311 the world s first apixaban oral dissolving film represents a transformational advancement in anticoagulant therapy was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( TAHO Pharma Announces Submission of New Drug Application (NDA) to the U.S. FDA for TAH3311 - The World's First Apixaban Oral Dissolving Film - Represents a Transformational Advancement in Anticoagulant Therapy )
Also on site :
- Kate Hudson Delivers Powerhouse Performance of 1966 Hit in New Olympics Promo
- ‘Tournament of Champions’ Season 7 Bracket Revealed: Here Are the Official Matchups
- Gary Borman, Keith Urban’s Longtime Manager, Announces Retirement & Closure of Borman Entertainment After 50 Years